Saturday, July 5, 2025 7/5/2025

Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease

Award Number: R01AG055624
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/15/2018
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease - ABSTRACT We aim to better understand the links between type 2 diabetes (T2D) and Alzheimer’s disease (AD). Although the literature supports their association, the underlying mechanisms are not known. A number of obesity-associated comorbidities contribute to cerebrovascular abnormalities in T2D; among them: impaired glucose control, low grade systemic inflammation, hypertension, dyslipidemia, and obstructive sleep apnea. These comorbidities provide possible mechanistic links between T2D and dementia. Importantly, this group of comorbidities (here referred to as “modifiable vascular factors”) improve with weight loss. In addition to the fact that T2D is related to a doubling of all-cause dementia, individuals with T2D and those with prodromal AD, share a cluster of CNS abnormalities (here referred to as “CNS impairments”): memory deficits, hippocampal atrophy, reductions in cerebral glucose uptake in AD-vulnerable regions, and decreased cerebral blood flow. This overlap in CNS abnormalities supports a potential common pathway for the brain abnormalities observed in T2D and prodromal AD. We propose that large weight loss, which results in improvements of these modifiable vascular factors, will lead to recovery of the above mentioned central nervous system (CNS) impairments associated with T2D. We will conduct a longitudinal study comparing 100 obese individuals with T2D undergoing bariatric surgery to an equivalent group of 40 obese individuals also with T2D who will not have surgery (and likely not lose weight or improve in the modifiable vascular factors). The anticipated large changes in weight after bariatric surgery present a unique opportunity to investigate how obesity is causally related to CNS impairments. Subjects, 35-55 years old, with baseline BMI of 30-50 kg/m2 and 50% female, will be studied twice, immediately pre-surgery (baseline) and one year post-surgery, and an equal interval for the non-surgical obese T2D group. CNS recovery from injury or stroke shows large individual variability, thus we will determine how sex, education, and fitness moderate CNS recovery of the impairments associated with T2D resulting from large weight loss. We will also ascertain whether glycemic control and other modifiable vascular factors and their change over one year mediate the relationships between weight loss and recovery of the CNS impairments during that period. Both T2D and dementia are significant public health problems. This study will provide evidence to justify prevention strategies targeting modifiable vascular risk factors that likely contribute to the increased risk of dementia among individuals with T2D. By targeting modifiable vascular factors at a young age, prior to potential irreversible brain deterioration, we will show the importance of this approach among young adults, when interventions may be most effective. We will utilize reliable and validated measures so as to ensure reproducibility. The study has a strong scientific premise and has been adequately powered. Success is assured by the access to participants, an excellent environment, and the experience and productivity of the investigators.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	5	6/10/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	5	1/19/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	5	2/22/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $782,563 )
2022	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	001	5	6/1/2022	NON-COMPETING CONTINUATION	$78,257
2022	2022	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	5	1/7/2022	NON-COMPETING CONTINUATION	$704,306
														Subtotal = $782,563

Issue Date FY: 2021 ( Subtotal = $806,134 )
2021	2021	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	4	2/5/2021	NON-COMPETING CONTINUATION	$806,134
														Subtotal = $806,134

Issue Date FY: 2020 ( Subtotal = $816,355 )
2020	2020	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	3	2/21/2020	NON-COMPETING CONTINUATION	$816,355
														Subtotal = $816,355

Issue Date FY: 2019 ( Subtotal = $833,313 )
2019	2019	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	2	1/3/2019	NON-COMPETING CONTINUATION	$833,313
														Subtotal = $833,313

Issue Date FY: 2018 ( Subtotal = $854,023 )
2018	2018	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Aging Research	000	1	4/6/2018	NEW	$854,023
														Subtotal = $854,023

Grand Total All Awards = $4,092,388

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease

Award Number: R01AG055624

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/15/2018

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer